Q-Restrain (SOT) for Lyme,Co-infection, Viruses

What is Q-Restrain (Q)?

At LEDA Medical we use Q-Restrain (formerly knows as SOT) for treatment of Lyme bacteria, co-infections, and other viruses. Essentially Q is the creation of a shutoff “key” that precisely fits a chosen “lock” portion of a cancer cell or pathogen. The “lock” is a specific section of DNA that normally controls an important function of the pathogen. The “key” binds to the “lock” and blocks the function thus killing the pathogen. After the cancer cell or pathogen dies the SOT compound is released and travels to the next target, thus fighting the cancer or infection 24/7 for months. In other words, Q works simply by shutting down the gene replication sequences of our target causing apoptosis (cell death) therefore eliminating the next life-cycle.

Q- Restrain therapy is not FDA-approved, or being studied under an Investigational New Drug Application (IND), which is a clinical investigation plan, submitted and allowed to proceed by the FDA.

Take SOT Questionnaire

For LEDA Patients ONLY

None LEDA Patients

Key Advantages of Q-Restrain (SOT)

Highly specific therapy and will only work for the patient that is was made for.
SOT therapy uses miRNA's to only influence certain gene expressions not to change genetic structure.
Able to cross the blood brain barrier with ease.
SOT has a stealth characteristic (meaning it is unnoticed by the body’s RNase)
Remains active in the blood stream for approximately 14-26 weeks (maybe longer) per dose.
SOT will work 24/7 and has no decreased efficacy with any concurrent technique except rarely chemotherapy and or radiation.
Can be used for cancer, Lyme, and co-infection therapy.

What species of Lyme and coinfections can be treated with Q-Restrain SOT therapy?

Additional viruses

HHV1/HSV1 – (Human Simplex Virus – Oral-Facial)
HHV2/HSV2 - Herpes Simplex Virus – Genital)
HHV6 (A & B) – Human Herpes Virus – 6
CMV – (Cytomegalovirus)
Coxsackie Virus (Type A & B)
VZV - Varicella Zoster (shingles)
EBV - Epstein-Barr Virus
HPV- (16/18) - Human Papilloma Virus
HPV- (6/11) - Human Papilloma Virus
HBV - Hepatitis B Virus
HCV - Hepatitis C Virus
HIV - Human Immunodeficiency Vir
HTLV1 – Human T-Cell Lymphotropic Virus

* It is not recommended to treat the same infection with SOT more than 3 times in a 12 month period.

What tests are used for Q-Restrain SOT?

We use a variety of testing to determine whether you are a possible candidate for SOT. You must have a positive lab result for a particular infection within the last 6 months.

What are the side effects?
Because it is derived from the patient’s own blood, the side effects are usually minimal. But may occur usually 2 weeks after administration. Patient may experience “Herx” like reactions, which include body aches, fatigue, headaches, fever and more.

How do I know if it’s working? Clinical & Laboratory findings improve. This would require a discussion with your treating clinician.

What is the process?

Patients will have a blood draw done, in which their blood sample is collected and will be shipped to RGCC labs in Greece. It takes about 4 weeks to create an Q-Restrain SOT therapy. When created it will be shipped back to our office for patient administration. Patients will come in the office for an iv infusion which typically takes up to one hour.

How often should patients carry out a follow-up test?
It depends on your treatment plan provided by your clinician.

Research Studyhttp://globalresearchonline.net/journalcontents/volume9issue2/Article-007.pdf